剖宫产切皮前辅助预防:系统评价与荟萃分析
该系统评价与荟萃分析纳入3项随机对照试验和1项前瞻性观察研究共2613名剖宫产妇女,比较切皮前头孢唑林联合辅助预防(大环内酯类或甲硝唑)与单用头孢唑林的效果。结果显示联合方案显著降低手术部位感染(RR 0.46, 95%CI 0.34-0.63)和住院时间(WMD -1.46, 95%CI -2.21至-0.71),但母体发热病率无显著差异。
要点
- 切皮前头孢唑林联合辅助预防可显著降低剖宫产手术部位感染风险。
- 联合方案与住院时间缩短相关,但母体发热病率无显著改善。
- 不同辅助抗生素方案的相对有效性仍需未来研究确定。
核心结论
- 切皮前头孢唑林联合辅助广谱预防优于单用头孢唑林,可降低手术部位感染和住院时间。
研究设计与样本
- 系统评价与荟萃分析,纳入3项随机对照试验和1项前瞻性观察研究,共2613名剖宫产妇女。
- 排除免疫功能低下(如HIV阳性)或剖宫产前诊断绒毛膜羊膜炎的妇女。
- 所有患者接受一线头孢唑林(1g或2g),比较单用头孢唑林与头孢唑林联合辅助治疗(阿奇霉素、甲硝唑或克拉霉素500mg口服或静脉)。
主要发现
- 手术部位感染显著降低(RR 0.46, 95%CI 0.34-0.63;3项随机对照试验)。
- 住院时间显著缩短(WMD -1.46, 95%CI -2.21至-0.71;2项随机对照试验)。
- 母体发热病率无显著差异(RR 0.38, 95%CI 0.11-1.25;2项随机对照试验)。
关键数值与推荐
- 手术部位感染:RR 0.46(95%CI 0.34-0.63),基于3项随机对照试验。
- 住院时间:WMD -1.46(95%CI -2.21至-0.71),基于2项随机对照试验。
- 母体发热病率:RR 0.38(95%CI 0.11-1.25),基于2项随机对照试验。
临床怎么用
- 对于剖宫产妇女,可考虑切皮前头孢唑林联合辅助预防(大环内酯类或甲硝唑)以降低手术部位感染。
- 联合方案可能缩短住院时间,但需权衡不同辅助抗生素的选择。
局限性
- 不同辅助抗生素方案的相对有效性尚未确定,需未来研究。
- 纳入研究数量有限,部分结局仅基于2项随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to systematically review the relative effectiveness of preincision cefazolin with or without adjunctive prophylaxis (macrolides or metronidazole) vs cefazolin alone in decreasing the incidence of postcesarean delivery surgical site infections. DATA SOURCES: We performed a systematic search on PubMed, Ovid EMBASE, Google Scholar, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials from October 25, 2020, to November 25, 2020, to identify studies comparing cefazolin with adjunctive macrolides or metronidazole with cefazolin alone. The reference lists were reviewed, and a manual search of articles published after the last database search was performed. STUDY ELIGIBILITY CRITERIA: Overall, 3 randomized controlled trials and 1 prospective observational study of reproductive-age women undergoing cesarean deliveries were included in the study. We excluded studies of women who were immunocompromised (eg, patients who were HIV positive) or women with a diagnosis of chorioamnionitis before cesarean delivery. All patients received first-line cefazolin (either cefazolin 1 g or 2 g). We compared preincision cefazolin alone with preincision cefazolin plus adjunctive therapy (500 mg, oral or intravenous formulations of azithromycin, metronidazole, or clarithromycin). METHODS: A total of 6 review authors independently assessed the risk of bias for each study, using the Cochrane Risk of Bias criteria. Synthesis and further appraisal were done using the Grading of Recommendations, Assessment, Development, and Evaluation levels and the American College of Obstetricians and Gynecologists appraisal guidelines. Disagreements were resolved by discussion. Treatment effects were evaluated using meta-analysis, and pooled relative risks and 95% confidence intervals were generated using random-effects models using the Review Manager 5 software (version 5.4.1). RESULTS: Overall, 3 randomized controlled trials and 1 prospective observational study representing 2613 women met the criteria for inclusion. Significant reductions in surgical site infections (relative risk, 0.46; 95% confidence interval, 0.34-0.63; 3 randomized controlled trials) and the duration of hospital stay (weighted mean difference, -1.46; 95% confidence interval, -2.21 to -0.71; 2 randomized controlled trials) were observed with preincision cefazolin and adjunctive prophylaxis compared with cefazolin alone. No significant difference was observed in maternal febrile morbidity (relative risk, 0.38; 95% confidence interval, 0.11-1.25; 2 randomized controlled trials). CONCLUSION: Our findings have provided evidence for the use of preincision adjunctive extended-spectrum prophylaxis with cefazolin over cefazolin alone. However, future investigations are required to establish the relative efficacies of different adjunctive antibiotic options.
引用
- Markwei MT, Babatunde I, Rathi N, et al. Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis. Am J Obstet Gynecol. 2021. PMID: 33964219. doi:10.1016/j.ajog.2021.04.259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。